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Abstract—Positron Emission Tomography using 2-[18F]-
2deoxy-D-glucose as radiotracer (FDG-PET) is currently one
of the most frequently applied functional imaging methods
in clinical applications. The interpretation of FDG-PET data
requires sophisticated mathematical approaches able to exploit
the dynamical information contained in this kind of data. Most
of these approaches are formulated within the framework of
compartmental analysis, which connects the experimental nuclear
data with unknown tracer coefficients measuring the effectiveness
of the tracer metabolism by means of Cauchy systems of
ordinary differential equations. This paper provides a coincise
overview of linear compartmental methods, focusing on the
analytical solution of the forward compartmental problem and on
the specific issues concerning the corresponding compartmental
inverse problem.
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I. INTRODUCTION
The metabolic pattern of most solid tumors shows an
increased glucose consumption, even under aerobic conditions
[20]. The mechanisms underlying this effect are not com-
pletely known, but a number of studies documented a direct
relationship between glucose consumption and aggressiveness
in cancer tissues. Although direct measurement of the contin-
uous flux of glucose molecules through lesion-populating cells
is extremely difficult, a reliable estimate was made possible
by the peculiar kinetic features of the radioactive glucose
analogue 2-[18F]-2deoxy-D-glucose (FDG).
In vivo, cancer FDG retention is dependent upon blood
glucose level [17], [23], drugs [9], and overall tracer avail-
ability in blood, which in turn depends on the amount of
administered activity and diffusion throughout the whole body,
after injection. Tracer concentration in blood also varies with
time as a consequence of physiological factors, related to
urinary elimination [9], accumulation in liver [8], absorption
by brain, and the different accumulation rates of the various
tissues [3].
Positron emission tomography (PET) measures the radiation
emitted by the target tissue in vivo, following an intravenous
administration of tracer molecules. The measuring device is
calibrated so that the activity distribution inside the tissue
is reconstructed. The output may vary from the estimate of
the concentration of activity in a subregion of the tissue at a
chosen instant, to the time course of the activity in a given
time interval. The independent time variable t [min] measures
the time interval from tracer infusion. In particular, FDG can
be used as injected tracer and FDG-PET is currently the most
used modality in this kind of functional imaging analysis.
In the present paper we provide an overview of how
mathematical modelling can be used to obtain a reliable
interpretation of FDG-PET data. Specifically, we will show
how systems of ordinary differential equations can be used
to connect the experimental data provided by FDG-PET to
unknown kinetic parameters that describe the effectiveness of
FDG metabolism in biological tissue.
The plan of the paper is as follows. Section 2 will intro-
duce compartmental analysis, as the most reliable tool for
the mathematical modelization of FDG-PET data. Section 3
will provide some results concerning the forward problem
associated to compartmental analysis and Section 4 will briefly
illustrate some aspects of the corresponding inverse problem.
Our conclusions will be offered in Section 5.
II. COMPARTMENTAL ANALYSIS
Compartmental analysis [13], [16] provides a mathematical
model relating PET image data to specific metabolic states or
chemical compounds of the tracer, taking also into account
their distribution in space, if needed. The metabolic states are
known as comportments, sources, or pools. A fundamental
requirement of compartmental modelling is the so-called well-
mixed assumption, which means that the tracer distribution
in each compartment is spatially homogeneous, and tracer
exchanged between compartments in instantaneously mixed.
Further conditions for applicability of compartmental analysis
can be found in [2], [4], [15], [22].
Each compartment denotes a specific metabolic condition of
FDG in the biological tissue. For example, FDG may be free
in the interstitial space between cellular membranes or trapped
within the cytosol by means of a biochemical process named
phosphorylation. Further, each compartment is characterized
by the related time dependent activity concentration. Finally,
it is understood that different compartments, such as free and
phosphorylated FDG, may occupy the same spatial volume;
conversely, if a chemical compound of the tracer occupies
volumes separated by a membrane, as occurs to free tracer in
interstitial tissue and cytosol, then the compound is associated
with two spatially distinct compartments, of possibly different
concentrations.
A compartmental model (CM) is given by an intercon-
nected set of compartments. The number of compartments
to be considered depends on the chemical, physiological,
and biological properties of the tracer to be modelled [4],
[12], [21]. We point out that that, in principle, blood should
be considered as a compartment; however, in compartmental
analysis the concentration of tracer inside blood is always
considered as known via either experimental measurements or
computational approaches. This specific concentration is called
input function (IF) and in the following it will be considered as
one of the problem data [22]. Therefore, the main ingredients
of a compartmental model for FDG-PET data relies on the
following items:
• The concentrations of the various pools are the state
variables of the CM.
• The time dependence of the state variables is determined
by tracer exchange.
• The flux of tracer between compartments occurs accord-
ing to mass conservation.
• The time rate of the concentration of each compartment
is set equal to the difference between the tracer that
enters and leaves the compartment, per unit time and unit
volume.
• The IF is the forcing function of the system providing
tracer supply to the interconnected compartments.
Application of the conservation law shows that concentrations
are related by a system of ordinary differential equations
(ODEs). Here it is assumed that all the initial concentrations
vanish, because there is no tracer available at the beginning of
each experiment. According to this mathematical model, the
state variables are the solutions of a Cauchy problem. We con-
sider linear ODEs with constant rate coefficients, representing
the rate of flux of tracer between compartments (for example,
the rate of phosphorylation of FDG molecules). The constants
are also termed transfer coefficients or microparameters [11].
If the rate coefficients and the initial state are given, then
the solution of the Cauchy problem (i.e., the compartmental
forward problem) provides a detailed description of tracer
kinetics. However, typical problems of compartmental analysis
require the determination of the rate constants such that the
corresponding solution complies with the measured overall
tissue concentration. From the viewpoint of mathematics, this
is a typical inverse problem.
III. COMPARTMENTAL ANALYSIS: FORWARD PROBLEM
The mathematical complexity of the forward problem for
compartmental analysis depends on the number of compart-
ments considered. As a starting point, the 1-compartment
model (1-CM) is an oversimplified model where there is only
one tissue compartment Cf with state variable Cf , accounting
for the overall tracer content, which is considered as free (i.e.,
not phosphorylated). The differential equation for Cf is
C˙f = −k2 Cf + k1 Cb , (1)
where Cb is the IF (i.e., the concentration in the blood com-
partment), k1 and k2 are the rate constants for incoming and
outgoing tracer. In other words, k1 Cb is the rate of incoming
flow of tracer per unit volume, while k2 Cf is the outgoing
flow per unit volume; thus, the net rate of tracer concentration
per unit volume, C˙f , is the difference between incoming and
outgoing flows, consistently with conservation of the mass
of tracer (note that in CM equations, the plus and minus
signs refer systematically to incoming and outgoing flows,
respectively, of the compartment considered). The solution of
equation (1) (vanishing at t = 0) is
Cf = k1
∫ t
0
e−k2 (t−τ)Cb(τ) dτ. (2)
The concentration Cf is proportional to k1, which is related
to the absorption capacity of the tissue. The parameter 1/k2
is related to the asymptotic equilibrium time.
Standard 2-compartment models (2-CMs) have been devel-
oped under the assumption that the intracellular processes of
phosphorylation and dephosphorylation of FDG are modelled
by the use of two compartments Cf and Cp, accounting for free
and phosphorylated tracer, respectively (see, e.g., [19], [22]
). However, more recent advances in biochemistry show that
G6Pase is anchored to the endoplasmic reticulum (ER) [10],
so that its action of hydrolysis of G6P and FDG6P, resulting
in the creation of a phosphate group and free molecules of
glucose and FDG, occurs after transport of the phosphorylated
forms into the ER by the transmembrane protein glucose-6-
phosphate transporter (G6PT) [14]. Then, free FDG in ER may
be released in cytosol. Further biochemical, pharmacological,
clinical, and genetic data lead to a natural interpretation of the
ER as a distinct metabolic compartment [6] and therefore to
the formulation of a 3-compartment model (3-CM).
From a formal viewpoint, 2-CM and 3-CM can be described
in a matrix form as follows:
C˙ =MC + k1 Cb e . (3)
In general, C is the n-dimensional column vector of state
variables, with n = 2, 3; M is a constant square matrix of
order n, with entries given by the rate coefficients; e is a
constant n-dimensional column vector. Addition of the initial
condition C(0) = 0 gives rise to a Cauchy problem for the
unknown state vector C . For 2-CMs we have that
M =
[
−(k2 + k3) k4
k3 −k4
]
, C =
[
Cf
Cp
]
, e =
[
1
0
]
(4)
while 3-CM equations can be written as
M =

−(k2 + k3) 0 k6k3 −k5 0
0 k5 −k6

 , C =

CfCp
Cr

 , e =

10
0

 .
(5)
The solution of the direct problem may be represented as
C(t;k, Cb) = k1
∫ t
0
eM (t−τ) Cb(τ) dτ e. (6)
where k is the vector of parameters defined as
k = (k1, k2, . . . , km)
T , with upper T denoting the transpose
and m depending on the CM adopted. The notation gives
evidence to the dependence of C on the rate constants and
the input function.
IV. COMPARTMENTAL ANALYSIS: INVERSE PROBLEM
The activity concentration measured by a PET scanner
results from superposition of various signals emitted, e.g.,
by tracer molecules carried by blood partially occupying the
ROI volume, molecules dispersed in the interstitial tissue, free
and phosphorylated molecules in cells. The tissue selected
for measurement of the activity concentration CT [Bq/ml]
is referred to as the target tissue. The time course of CT ,
also regarded as the tissue response, is obtained from the ROI
analysis of a dynamic series of images (see, e.g., [4], [22]).
We recall that data are corrected for attenuation and, possibly,
other systematic sources of error. Obviously, the reconstructed
value of CT is functionally dependent on characteristics of
the IF and of the target tissue, the injected dose, and the
physiologic conditions of the patient. From a mathematical
viewpoint, the connection between the compartmental model
and the measured PET data is given by the inverse problem
equation
CT = α
T
C(t;k, Cb) , (7)
where α is a row vector with components depending on
physiological parameters.
As a first step in the solution of the inverse problem,
it must be shown that the rate coefficients are uniquely
determined by data. This requirement puts severe limitations
on the number of coefficients allowed, and hence on the
number of compartments-metabolic states and the related
interconnections to be considered. The result is a sort of
compromise between the need for simplification in the formal
description and exhaustiveness in the representation of reality.
Here we consider models resulting from either two or three
compartments. In the case of linear compartmental models
as the ones considered in this paper, a standard procedure
for proving uniqueness results is possible: denoting as f˜(s)
the Laplace transform of a function f(t) and assuming that
appropriate regularity conditions are satisfied, the procedure
can be sketched as follows:
1) Consider the time derivative of both sides of (7) at the
time t = 0:
C˙T (0) = αC˙(0) + Vb C˙i(0).
According to eq (3), C˙(0) is replaced by k1 Cb(0) e.
Hence it follows by substitution that
k1 =
C˙T (0)− Vb C˙i(0)
αeCb(0)
. (8)
This shows that, in principle, k1 is directly determined
by data, if Cb(0) > 0.
2) Consider the Laplace transform of system (3), with
vanishing initial conditions, and equation (7). Then
(s I −M) C˜ = k1 C˜i e (9)
C˜T = αC˜ + Vb C˜i, (10)
where I denotes the identity matrix.
3) Consider the solution C˜ of the linear system (9), which
is given by
C˜ = k1 (s I −M)
−1
e C˜i = k1
Q(s, kˆ)
D(s; kˆ)
C˜i (11)
where D(s, kˆ) is the determinant of the matrix s I−M ,
expressed as a polynomial of s of degree n, with
coefficients depending on kˆ = [k2, ..., km]
T ; similarly,
Q(s, kˆ) is a polynomial of degree smaller than n.
Substitution into (10) of C˜ leads to
C˜T − Vb C˜i = k1
Q(s, kˆ)
D(s; kˆ)
C˜i. (12)
where C˜T and C˜i are given.
4) Any alternative set h of kinetic parameters consistent
with the data must satisfy equation (12), with k replaced
by h. It follows by comparison that
k1
Q(s, kˆ)
D(s; kˆ)
= h1
Q(s, hˆ)
D(s; hˆ)
. (13)
We know from (8) that h1 = k1. Thus, if there are no
common roots between the polynomials Q and D, then
equation (13) is equivalent to
Q(s, hˆ) = Q(s; kˆ), D(s, hˆ) = D(s; kˆ). (14)
5) If equations (14) imply hˆ = kˆ, then identifiability is
proved.
We conclude this general discussion on the uniqueness issue
with three comments:
• In general, point 5) may be extremely challenging and
specific mathematical assumptions must be introduced to
deal with it.
• If physiological parameters contained in α are considered
as unknowns in the inverse problem, then they have to be
properly considered in the discussion of identifiability.
• There are still open questions on the analysis of iden-
tifiability for nonlinear compartmental systems, e.g.,
when fluxes between compartments are modelled by
the Michaelis-Menten law; a comparison of currently
available techniques can be found in [5].
In conclusion of this Section, we point out that the sec-
ond aspect concerning the compartmental inverse problem is
related to the numerical solution of equation (7). From an
inverse problem perspective, that equation can be summarized
as
CT = Ft(k) , (15)
where Ft : R
n
+ → C
1(R+,R) is given by
Ft(k) = α
T
C(t;k, Cb) . (16)
Equation (15) is clearly a non-linear zero-finding problem
that can be numerically addressed by means of optimization
algorithms. It must me pointed out that the operator Ft
is compact and therefore problem (15) is ill-posed in the
sense of Hadamard [1]. It follows that, at some stage of the
optimization process, a regularization step must be introduced
[7], [18].
V. CONCLUSIONS
This paper provides a coincise overview of some of the
mathematical aspects of compartmental analysis. We formu-
lated the problem in the case of linear models and considered
both the solution of the Cauchy system in the case of 2D and
3D models, and the discussion of uniqueness issues associated
to the inverse problem.
Compartmental analysis is still an important mathemati-
cal tool for the interpretation of nuclear medicine data for
many different physiological and clinical applications. Current
development of this approach include parametric imaging
methods that process PET raw data in order to provide
spatially-resolved maps of the kinetic parameters, applications
to experimental modalities other than FDG-PET (for example,
data acquired by means of ligand tracer technologies), and
formulation of models that benefit of exploiting more details
physiological information within the compartmental equations
framework.
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